HIV-associated pulmonary arterial hypertension: from bedside to the future.

@article{Correale2015HIVassociatedPA,
  title={HIV-associated pulmonary arterial hypertension: from bedside to the future.},
  author={Michele Correale and G A Palmiotti and Maria Maddalena Lo Storto and Deodata Montrone and Maria Pia Foschino Barbaro and Matteo di Biase and Donato Lacedonia},
  journal={European journal of clinical investigation},
  year={2015},
  volume={45 5},
  pages={515-28}
}
Pulmonary arterial hypertension (PAH) is a life-threatening complication of HIV infection. The prevalence of HIV-associated PAH (HIV-PAH) seems not to be changed over time, regardless of the introduction of highly active antiretroviral therapy (HAART). In comparison with the incidence of idiopathic PAH in the general population (1-2 per million), HIV-infected patients have a 2500-fold increased risk of developing PAH. HIV-PAH treatment is similar to that for all PAH conditions and includes… CONTINUE READING